Remember, the last mile is still part of the race. Go break some eggs.
👀 The Read
SEND isn't the box you check last.
It’s actually on your critical path —
and the provider you pick moves your filing date.
Ask ten teams about SEND and most will wave it off as a formatting step — the clerical thing that happens after the real work is done. That's exactly how it becomes the thing standing between you and your IND.
Here's what SEND actually is. The Standard for Exchange of Nonclinical Data is the structured, machine-readable format your tox study data has to be in for FDA to review it. It isn't optional, depending on who builds it can take anywhere from a week to two months after your final report for delivery.
Sit with that timeline. Your study is done. Your report is signed. And you still can't file, because the dataset isn't ready. That's not a formatting delay — that's your submission date moving to the right.
Two things decide how much SEND costs you.
→ The first is when you start it. SEND can often be built in parallel as the study wraps, not bolted on after the report is final. Wait until the end and you add the entire turnaround to the back of your timeline; plan for it and you absorb almost none of it.
→ The second is who builds it, and the range here is enormous — in both price and speed. I've seen SEND quotes north of $60,000, with delivery landing after the sponsor's own target IND date. For a dataset. That's the trap: you assume SEND is a commodity, take whatever the CRO bundles in, and find out too late it was neither cheap nor fast.
For what it's worth, I've used PointCross Life Sciences for my own SEND work for years — consistently faster and a fraction of the quotes I see elsewhere, with an instant quote generator that gives you a price and a delivery date without a single email. If you're up against an IND date, that's worth knowing.
The clean version is simple: treat SEND as part of the study, not the afterthought. What trips teams up is discovering, at the finish line, that the last step is the one with no slack left in it.
The Misconception: SEND is a formatting box you check at the very end.
The Correction: SEND is on your critical path to the IND. Plan it early so it runs in parallel with study close-out instead of adding weeks to the back of your timeline, and price it deliberately — turnaround and cost vary wildly by provider. Don't let the final step be the one that slips your filing.
⚡ Get an instant SEND quote
No sales call, no waiting on a proposal. Plug in your study, see your number and delivery date on the spot. Timeline and price delivered in minutes.
📌 Looking for a community of nonclinical professionals who speak your language? Well you found it. Join for free today → https://www.nonclinical.academy/